EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-α/NF-ĸB/p-RIPK3 Pathway

Sasivimon Promsan, Nattavadee Pengrattanachot, Nichakorn Phengpol iD, Prempree Sutthasupha, La-Ongdao Thongnak, Krit Jaikumkao iD, Anusorn Lungkaphin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sasivimon Promsan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Chiang Mai University, Intravaroros Road, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, Receptor-Interacting Protein Serine-Threonine Kinases, Necroptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Golden Jubilee Ph.D. Program, National Research Council of Thailand, Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a risk factor for chronic kidney disease. The expansion of adipose tissues in obesity induces insulin resistance and low-grade systemic inflammation, promoting kidney damage. Our previous studies have demonstrated that agomelatine (AGOM) exerts renoprotective effects in experimental models of obesity and insulin resistance through various mechanisms, including the attenuation of ER stress and oxidative stress. This study aimed to further explore the effects of agomelatine on renal inflammation, insulin signaling, and necroptosis in obese, insulin-resistant rats. Obesity was induced in rats with a high-fat diet for 16 weeks, followed by 4 weeks of treatment with 20 mg kg−1 day−1 of AGOM or 10 mg kg−1 day−1 of pioglitazone (PIO). The results showed that insulin resistance was improved after treatment with AGOM and PIO, as demonstrated by the reduction in fasting plasma glucose, insulin, and HOMA-IR. Both treatments restored the levels of renal insulin signaling proteins. Moreover, AGOM inhibited TNFα, TNFR1, NF-ĸB, COX2, and IL1β, which attenuated the necroptosis-related proteins RIPK3 and MLKL. AGOM also prevented kidney DNA fragmentation, as detected by the TUNEL assay. In an obese condition, the level of the tight junction protein claudin-1 (CLDN1) was enhanced after being treated with AGOM. In conclusion, the novel mechanisms associated with AGOM and involved in limiting kidney injury were the inhibition of the TNFα/NF-ĸB/p-RIPK3 pathway and a reduction in inflammation and necroptosis. This suggested that AGOM could be an effective treatment for inhibiting kidney dysfunction in cases of obesity and insulin resistance. These findings open new avenues for the management of renal dysfunction, with implications for personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceObesityReceptor-Interacting Protein Serine-Threonine KinasesNecroptosisInflammationAcetamidesAnimalsRatsTumor Necrosis Factor-alphaMaleNF-kappa BSignal TransductionKidneyDiet, High-FatNaphthalenes

Stichwörter der Autor:innen

agomelatineinflammationinsulin resistancekidney injurynecroptosisobesity

Substanzen

Tumor Necrosis Factor-alphaReceptor-Interacting Protein Serine-Threonine KinasesAcetamidesNF-kappa BagomelatineRipk3 protein, ratNaphthalenes

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Chiang Mai University, Intravaroros Road, Chiang Mai 50200, Thailand.
  • Division of Physiology, School of Medical Science, University of Phayao, Phayao 56000, Thailand.
  • Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, Thailand.
  • Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Functional Foods for Health and Disease, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Functional Food Research Center for Well-Being, Multidisciplinary Research Institute, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Nichakorn Phengpol, Krit Jaikumkao, Anusorn Lungkaphin

Förderung

  • Royal Golden Jubilee Ph.D. Program
  • National Research Council of Thailand
  • Chiang Mai University
  • Fundamental Fund, Chiang Mai University
  • Faculty of Medicine Research Fund, Chiang Mai University
  • National Research Council of Thailand (NRCT) and Chiang Mai University
  • Functional Foods Research Center for Well–Being, Chiang Mai University

Zitieren

APA

Promsan, S., Pengrattanachot, N., Phengpol, N., Sutthasupha, P., Thongnak, L. O., Jaikumkao, K., & Lungkaphin, A. (2025). Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-α/NF-ĸB/p-RIPK3 Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051940

Vancouver

Promsan S, Pengrattanachot N, Phengpol N, Sutthasupha P, Thongnak LO, Jaikumkao K, et al. Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-α/NF-ĸB/p-RIPK3 Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051940

BibTeX
@article{Promsan2025,
  author = {Promsan, Sasivimon and Pengrattanachot, Nattavadee and Phengpol, Nichakorn and Sutthasupha, Prempree and Thongnak, La-Ongdao and Jaikumkao, Krit and Lungkaphin, Anusorn},
  title = {Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-α/NF-ĸB/p-RIPK3 Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051940}
}
Kostenlos starten →